Solara Active Pharma Sciences Complete Financial Statements
SOLARA • Review detailed financials to uncover trends, confirm thesis & journal trades
8 Years of Data
2025 - 2018
Complete Financial Data Export
Export complete financial statements for Solara Active Pharma Sciences (SOLARA).
Downloads include all available records across all periods.
For market performance, see the
SOLARA stock price today
.
Profitability Ratios
Net Profit Margin
-3.18%
2025 data
EBITDA Margin
11.15%
2025 data
Operating Margin
11.00%
2025 data
Return on Assets
-0.45%
2025 data
Return on Equity
-0.91%
2025 data
Balance Sheet Ratios
Current Ratio
3.82
2025 data
Debt to Equity
2.03
2025 data
Equity Ratio
49.15%
2025 data
Asset Turnover
0.14
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
-9.5%
Year-over-Year
Net Profit Growth
-225.0%
Year-over-Year
EBITDA Growth
-43.5%
Year-over-Year
Expense Growth
-2.4%
Year-over-Year
Assets Growth
-5.1%
Year-over-Year
Equity Growth
+17.1%
Year-over-Year
Liabilities Growth
-5.1%
Year-over-Year
Operating Cash Flow Growth
+95.4%
Year-over-Year
Investing Cash Flow Growth
-825.0%
Year-over-Year
Financing Cash Flow Growth
-70.8%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 314 | 279 | 320 | 347 | 301 | 364 | 302 | 426 | 385 | 354 | 212 | 342 | 367 | 337 | 402 | 405 | 454 | 412 | 105 | 404 | 309 | 353 | 435 | 356 | 392 | 335 | 350 | 344 | 303 | 360 |
| Expenses | 279 | 228 | 262 | 286 | 412 | 322 | 243 | 393 | 332 | 333 | 436 | 311 | 349 | 318 | 350 | 330 | 345 | 315 | 199 | 300 | 247 | 265 | 321 | 283 | 321 | 267 | 266 | 295 | 263 | 294 |
| EBITDA | 35 | 51 | 58 | 62 | -111 | 43 | 59 | 34 | 53 | 21 | -224 | 31 | 18 | 20 | 52 | 75 | 109 | 97 | -94 | 104 | 62 | 88 | 114 | 73 | 71 | 68 | 84 | 49 | 40 | 66 |
| Operating Profit Margin % | 11.00% | 17.00% | 18.00% | 18.00% | -38.00% | 12.00% | 19.00% | 8.00% | 13.00% | 5.00% | -106.00% | 8.00% | 3.00% | 4.00% | 11.00% | 18.00% | 22.00% | 22.00% | -98.00% | 25.00% | 17.00% | 24.00% | 25.00% | 19.00% | 17.00% | 19.00% | 23.00% | 14.00% | 13.00% | 17.00% |
| Depreciation | 25 | 24 | 24 | 25 | 25 | 25 | 25 | 26 | 27 | 26 | 26 | 29 | 28 | 28 | 28 | 28 | 27 | 28 | 28 | 28 | 24 | 26 | 27 | 24 | 23 | 23 | 24 | 19 | 19 | 21 |
| Interest | 21 | 29 | 24 | 28 | 31 | 31 | 27 | 24 | 22 | 25 | 25 | 22 | 22 | 23 | 24 | 17 | 25 | 19 | 18 | 19 | 20 | 20 | 21 | 20 | 22 | 19 | 19 | 20 | 18 | 23 |
| Profit Before Tax | -10 | -2 | 11 | 8 | -167 | -14 | 8 | -17 | 5 | -29 | -275 | -19 | -31 | -31 | 1 | 30 | 57 | 50 | -140 | 57 | 18 | 42 | 66 | 29 | 26 | 27 | 41 | 9 | 3 | 22 |
| Tax | 0 | 0 | 0 | 0 | 89 | 0 | 0 | 0 | 1 | -10 | 0 | -9 | -33 | -15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Net Profit | -10 | -2 | 11 | 8 | -255 | -14 | 8 | -17 | 4 | -19 | -275 | -10 | 2 | -17 | 0 | 30 | 57 | 50 | -140 | 57 | 18 | 42 | 66 | 29 | 26 | 27 | 41 | 9 | 3 | 22 |
| Earnings Per Share (₹) | -2.36 | -0.93 | 2.46 | 2.54 | -70.93 | -3.50 | 2.03 | -4.77 | 1.05 | -5.43 | -72.07 | -2.77 | 0.53 | -4.56 | 0.12 | 8.27 | 15.57 | 13.95 | -38.93 | 19.21 | 6.78 | 15.75 | 18.47 | 11.21 | 10.17 | 10.29 | 16.00 | 3.47 | 0.23 | 8.96 |
Related Pages for Solara Active Pharma Sciences
Additional stock information and data for SOLARA
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Total Assets | 2,232 | 2,351 | 2,899 | 2,945 | 2,614 | 2,154 | 1,960 | 1,822 |
| Current Assets | 729 | 801 | 1,188 | 1,239 | 1,058 | 672 | 648 | 608 |
| Fixed Assets | 1,193 | 1,268 | 1,364 | 1,356 | 1,382 | 1,397 | 1,218 | 1,086 |
| Capital Work in Progress | 280 | 256 | 239 | 239 | 88 | 41 | 40 | 72 |
| Investments | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 1 |
| Other Assets | 757 | 825 | 1,295 | 1,350 | 1,144 | 716 | 702 | 663 |
| LIABILITIES | ||||||||
| Total Liabilities | 2,232 | 2,351 | 2,899 | 2,945 | 2,614 | 2,154 | 1,960 | 1,822 |
| Current Liabilities | 191 | 172 | 296 | 354 | 232 | 333 | 344 | 315 |
| Non-Current Liabilities | ||||||||
| SHAREHOLDERS' EQUITY | ||||||||
| Total Equity | 1,097 | 937 | 1,502 | 1,527 | 1,593 | 1,090 | 960 | 769 |
| Share Capital | 40 | 36 | 36 | 36 | 36 | 27 | 26 | 25 |
| Reserves & Surplus | 1,054 | 898 | 1,464 | 1,489 | 1,553 | 963 | 826 | 739 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 213 | 109 | 156 | -242 | 156 | 242 | 166 | 49 |
| Investing Activities | -37 | -4 | -81 | -243 | -106 | -359 | -113 | -86 |
| Financing Activities | -181 | -106 | -113 | 334 | 93 | 97 | -23 | 68 |
| Net Cash Flow | -5 | 0 | -38 | -151 | 142 | -20 | 30 | 32 |